Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Levels of
carcinoembryonic antigen
(
CEA
), alpha-fetoprotein (AFP), ferritin and alpha 2-pregency associated glycoprotein (alpha-2-PAG) were determined in patients with confirmed lung cancer at the time of diagnosis and in serial determinations during and after radio- or chemotherapy. Whereas AFP levels were not elevated in patients with lung cancer, increased levels of
CEA
, ferritin and alpha-2-PAG were found in more than 50% of the patients. The results suggest that determination of
CEA
, ferritin and alpha-2-PAG in the serum of patients with lung cancer may be useful to detect metastases or recurrences and to monitor the results of treatment. Furthermore, in this study
CEA
and ferritin could be demonstrated in extracts of lung
tumor
tissues by specific antisera.
...
PMID:Carcinoembryonic antigen, alpha 1-fetoprotein, ferritin, and alpha 2-pregnancy associated glycoprotein in the serum of lung cancer patients and its demonstration in lung tumor tissues. 7 56
A glycoprotein has been isolated from the colonic lavages of healthy individuals that is immunologically equivalent to
carcinoembryonic antigen
purified from
tumor
tissue. The NH2-terminal sequence of the glycoprotein from normal colon lavages is Lys-Leu-Thr-lle-Glu-Ser-Thr-Pro-Phe-(Asn)-Val-Ala-Glu-Gly-Lys-Glu-Val-(Leu,lle)-(Leu,lle)-(Leu,lle)-Val-(His,Arg?)-?-(Leu,lle). This is homologous to the NH2-terminal sequence of 23 of the first 24 amino acids of
carcinoembryonic antigen
isolated from
tumor
tissue.
...
PMID:Amino-terminal sequence of a carcinoembryonic antigen-like glycoprotein isolated from the colonic lavages of healthy individuals. 7 56
The concentration of beta2-microglobulin (beta2m) and
carcinoembryonic antigen
(
CEA
) was measured radioimmunologically in the sera of 79 patients with malignant disorders and 15 patients with chronic pancreatitis. Elevated levels of beta2m and
CEA
were found in 11 out of 22 patients with carcinoma of the pancreas, which sets off this malignancy from chronic pancreatitis and other malignant tumors. Only 3 patients with carcinoma of the pancreas exhibited serum levels within the normal range for both parameters and none of the patients with chronic pancreatitis was shown to have elevated levels of beta2m. The simultaneous determination of beta2m and
CEA
suggests itself for the diagnosis of pancreatic malignancy especially in the case of a tentative diagnosis of a pancreatic
tumor
.
...
PMID:[The significance of beta2-microglobulin and carcinoembryonic antigen in the diagnosis of the carcinoma of the pancreas (author's transl)]. 7 94
In 53 p.c. of 175 patients with bronchial carcinoma the
carcinoembryonic antigen
(
CEA
) was elevated at the time of diagnosis. In patients with small well bordered tumors (T 1/2) 31 p.c. proved pathological
CEA
-values in comparison to 80 p.c. in patients with heamatogenic metastases. After radical
tumor
resection (36 patients) elevated
CEA
-levels returned to normal ranges within 5 weeks. No decrease could be observed after palliative operations (16 patients). If there existed haematogenic metastases normal
CEA
-values increased postoperative. Such an increase occured up to ten weeks before metastases could be found by other methods. In cases of bronchial carcinoma
CEA
-measurements are usefull to evaluate the effect of operation and in the follow up time. It should be carried out on principle in those patients which can be considered for a surgical therapy.
...
PMID:[The carcinoembryonic antigen (CEA) in bronchial carcinoma before and after operation (author's transl)]. 7 67
Leukocyte migration tests under agarose (Clausen technique) were performed in 28 patients tentatively diagnosed as having any malignancy with the use of a 3 M KCl-extract panel prepared from bronchogenic, gastric, colonic, renal, and mammary carcinoma, corresponding normal tissues,
carcinoembryonic antigen
(
CEA
), and human encephalitogenic protein (HEP). 17 out of 22 proven carcinoma patients showed sensitization by reaction with optimal concentrated KCl-extract of cancer from the same organ type as their own
tumor
. In some cases positive reactions could be observed also with normal tissue antigen (NTA) of
tumor
organ type (7/22) or with an additional carcinoma extract of organ type differing from patients own primary tumor (8/22). Gastrointestinal carcinomas, especially, showed sensitization to
CEA
(7/12) contrary to nongastrointestinal carcinomas (1/10). With HEP no positive reactivity could be found (0/10). With the use of
tumor
antigen panel (5 antigens) only few positive reactions (MI less than 0.80 or greater than 1.20) could be observed in 6 patients with nonmalignant diseases (1/30 tests) and 8 healthy blood donors (1/40 tests). A widespread individual screening program using tissue antigens for patients suspected of malignancies could give a pattern of reactivities and improve the recognition of cell-mediated sensitization against
tumor
tissues.
...
PMID:Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose. 8 Jul 56
Evidence has been reported for at least two common
tumor
-associated antigens, or antigenic determinants, in human cystadenocarcinomas of the ovary that are apparently absent in tissues of normal reproductive organs. These antigenic determinants are immunologically distinct from
carcinoembryonic antigen
, alpha-fetoprotein, ferritins and histocompatibility antigens. One of these two ovarian cystadenocarcinoma-associated antigens (OCAA) is not detectable in any ovarian carcinomas except serous or mucinous types, other gynecologic or nongynecologic malignancies thus far tested, while the second antigen is present in about 90% of all gynecologic tumors and occasionally in breast and colon tumors. OCAA has been purified and partially characterized. It is a high molecular weight glycoprotein which carries the unique ovarian
tumor
-specific antigenic determinant along with some normal cross-reacting determinants. High levels of this glycoprotein antigen have been detected in the sera of ovarian cancer patients with advanced disease by the radioimmunoassay inhibition technique. The serial determination of circulating OCAA appeared to correlate with
tumor
volume as well as the clinical status of the patients.
...
PMID:Ovarian tumor antigens. 8 12
beta2m was determined by radioimmunoassay in 43 serums from healthy blood donors. Serum concentrations varied from 0.67 to 1.9 mg/l with a mean of 1.29 mg/l. Reproductibility and sensitivity of the method were evaluated. 66 patients with advanced
neoplasia
were studied. Serum beta2m was greater than 2 mg/l in 70% of the cases and
carcinoembryonic antigen
(
CEA
) in 54%. In 26 documented cases with tumor progression and 14 with regression, associated variations of
CEA
were formed more frequent and of greater magnitude than those of beta2m.
...
PMID:[Comparative study of carcino-embryonic antigen and beta2-microglobulin. Methodological study and clinical interpretation (author's transl)]. 8 78
Several authors have observed that the plasma levels of
carcinoembryonic antigen
(
CEA
) in patients with neuroblastoma were significantly elevated. The present study was undertaken to investigate the nature of
CEA
activity in neuroblastoma tissue. This
tumor
tissue contains a small amount of
CEA
-like substance reacting with anti-
CEA
serum which is characterized by gamma-globulin electrophoretic mobility, a molecular weight that is approximately equal to that of albumin (4.6S) by gel filtration, and a glycoprotein staining with periodic acid-Schiff (PAS). According to the double immunodiffusion method, this antigen is partially identical to purified
CEA
of colon carcinoma, and is completely identical to nonspecific crossreacting antigen (NCA). This antigen is, therefore, referred to not as the
CEA
as described by Gold, but as NCA in neuroblastoma tissue. The elevation of plasma
CEA
activity in patients with neuroblastoma may be due to the release of NCA from
tumor
cells, or to the destruction tissues by metastasis, of normal which are rich in NCA, or to a combination of both.
...
PMID:Immunologic and biochemical studies on the carcinoembryonic antigen-like substance in human neuroblastoma. 8 82
A comparative study of
carcinoembryonic antigen
(
CEA
) and beta 2-microglobulin (beta 2-MG) in serum was made by radioimmunoassay in 77 women with genital cancer. With a positive level defined as 5 ng of
CEA
/ml and 3.0 microgram of beta 2-MG/ml,
CEA
was positive in 31% of the women with cancer of the corpus, 36% of those with cancer of the cervix and 36% of those with cancer of the ovary the corresponding figures for beta 2-MG were 6%, 27% and 56%, respectively. The additional use of beta 2-MG provided an increase in positive results, especially in cases of cancer of the ovary. A direct relationship between the extent of
tumor
and serum marker level was more evident for beta 2-MG than
CEA
. There was no correlation between serial levels of
CEA
and beta 2-MG in most patients.
CEA
levels appeared to predict subsequent
tumor
behavior more accurately in patients with good prognoses (ie, complete or partial
tumor
response), whereas beta 2-MG levels gave the same prediction in those with bad prognoses (ie, nonresponsive or progressive
tumor
).
...
PMID:Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer. 8 69
Tumor
-specific antisera against dehistonized chromatin isolated from transplantable colon adenocarcinoma (from male noninbred Sprague-Dawley rats) were produced. The specificities of these antisera were determined by complement fixation. In the presence of these antisera, only chromatin from colon adenocarcinoma significantly fixed complement, whereas chromatins isolated from normal rat colon epithelia were inactive. Administration of 1,2-dimethylhydrazine to rats produced an early change in the immunospecificity of colon epithelial chromatin similar to that for colon adenocarcinoma. Several lines of experimental evidence indicated that nuclear antigen was not a
carcinoembryonic antigen
-like substance. Common antigens were also present in human colon adenocarcinomas.
...
PMID:Immunospecificity of nuclear nonhistone protein-DNA complexes in colon adenocarcinoma. 8 36
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>